Literature DB >> 16231587

Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).

E Capristo1, L Miele, A Forgione, V Vero, S Farnetti, G Mingrone, A V Greco, G Gasbarrini, A Grieco.   

Abstract

BACKGROUND AND OBJECTIVES: Metabolic alterations are a common feature in patients affected by non-alcoholic steato-hepatitis (NASH). A strong correlation exists between overweight, in particular visceral fat accumulation, and prevalence of NASH, especially in men. Thus, diet-induced weight loss represents a fundamental tool in disease management of these patients. The aim of the present study was to evaluate body composition and nutrient utilisation in patients with NASH, comparing them with patients affected by chronic hepatitis related to hepatitis C virus (HCV) infection and with healthy subjects.
MATERIALS AND METHODS: Twenty male outpatients with NASH (age: 41 +/- 11 yr; BMI: 26.2 +/- 2.1 kg/m2) and 14 HCV male patients (age 44.6 +/- 13 yr; BMI: 24.8 +/- 2.8 kg/m2) were enrolled in the study. A group of 20 healthy male subjects (age: 39 +/- 10 yr; BMI: 23.3 +/- 1.1 kg/m2) were studied as controls. Body composition was assessed by anthropometry and dual-energy X-ray absorptiometry; resting metabolic rate and nutrient oxidation by indirect calorimetry. A 7-day food diary was collected. The main biochemical parameters were measured using standardised laboratory techniques.
RESULTS: Body weight was higher in NASH patients with respect to HCV patients and control subjects (respectively 75.2 +/- 8.9 vs 68.5 +/- 9.4 and vs 67.0 +/- 8.0 kg; P < 0.01) and this was essentially due to fat mass increase. Fat-free mass reduction was found in HCV patients with respect to both NASH and control subjects. Patients with NASH had a significantly higher waist circumference (P < 0.01) and a lower resting metabolic rate (RMR) with respect to HCV and control subjects. Energy intake was significantly higher in NASH patients (P < 0.01) compared to the other two groups.
CONCLUSIONS: NASH patients showed an increase in body weight, fat mass and visceral fat accumulation with respect to HCV and control subjects. The reduction in RMR, coupled with increase energy intake may explain the body composition alterations found in these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231587

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

Review 1.  Benefits of lifestyle modification in NAFLD.

Authors:  Stephen A Harrison; Christopher Paul Day
Journal:  Gut       Date:  2007-10-02       Impact factor: 23.059

Review 2.  Non-Alcoholic Fatty Liver Disease, an Overview.

Authors:  Asia Muhammad Nd
Journal:  Integr Med (Encinitas)       Date:  2019-04

Review 3.  Clinical approaches to non-alcoholic fatty liver disease.

Authors:  Katherine J P Schwenger; Johane P Allard
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 4.  Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.

Authors:  Alessandro Federico; Claudio Zulli; Ilario de Sio; Anna Del Prete; Marcello Dallio; Mario Masarone; Carmela Loguercio
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 5.  Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

Authors:  Ludovico Abenavoli; Natasa Milic; Valentina Peta; Francesco Alfieri; Antonino De Lorenzo; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Current treatments in nonalcoholic steatohepatitis.

Authors:  Dawn M Torres; Stephen A Harrison
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

Review 7.  4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

Authors:  Francesca Maria Trovato; Daniela Catalano; Giuseppe Musumeci; Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-12-07       Impact factor: 6.543

Review 8.  Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss.

Authors:  Violeta B Popov; Joseph K Lim
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

9.  Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study.

Authors:  Silvia Marinho Ferolla; Teresa Cristina Abreu Ferrari; Maria Luíza Pereira Lima; Tâmara Oliveira Reis; Wilson Campos Tavares; Osvaldo Flávio Melo Couto; Paula Vieira Texeira Vidigal; Maria Arlene Fausto; Cláudia Alves Couto
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365

10.  Intake of Nutrients, Fiber, and Sugar in Patients with Nonalcoholic Fatty Liver Disease in Comparison to Healthy Individuals.

Authors:  Hamid Zolfaghari; Gholamreza Askari; Fereydoun Siassi; Awat Feizi; Gity Sotoudeh
Journal:  Int J Prev Med       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.